Skip to main content
logo
AgomAb Therapeutics NV (AGMB)
NASDAQ: AGMB · Real-Time Price · USD
14.85
-0.15 (-1.00%)
At close: Aug 11, 2026, 4:00 PM EDT
14.85
0.00 (0.00%)
After-hours: Aug 11, 2026, 4:10 PM EDT

AgomAb Therapeutics NV Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Net Income
-66.65-62.55-46.27-11.39
Depreciation & Amortization
0.20.220.310.1
Stock-Based Compensation
5.235.361.072.16
Other Adjustments
0.713.27-1.75-19.8
Changes in Accounts Payable
4.052.36-0.233.69
Changes in Income Taxes Payable
---0-0
Changes in Unearned Revenue
-0.70.75-0.4-0.58
Changes in Other Operating Activities
-0.69-1.150.441.24
Operating Cash Flow
-56.73-51.74-46.83-24.59
Operating Cash Flow Growth
----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Capital Expenditures
--0-0.68-
Purchases of Investments
--30-40
Cash Acquisitions
--3--
Investing Cash Flow
-30-33-0.6840

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Issuance of Common Stock
163.9-97.0679.87
Net Common Stock Issued (Repurchased)
163.9-97.0679.87
Other Financing Activities
-1.4-0.34-0.29-0.55
Financing Cash Flow
164.9-0.3496.7679.32

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Foreign Exchange Rate Adjustments
0.050.05-0.2-
Net Cash Flow
78.17-85.0849.2694.73

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Free Cash Flow
-56.73-51.75-47.5-24.59
Free Cash Flow Growth
----
Free Cash Flow Per Share
-2.75-95.62-87.79-45.45
Levered Free Cash Flow
-63.79-60.37-46.82-6.95
Unlevered Free Cash Flow
-63.08-57.1-48.57-28.36
SEC Filings: 10-K · 10-Q